Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial

Se-hoon SHIM; Young-Sup WOO; Ji-Sun KIM; In-Soo HEO; Hee-jung YOON; Hyung-Mo SUNG; Jonghun LEE; Won-Myong BAHK; Se-hoon SHIM; Young-Sup WOO; Ji-Sun KIM; In-Soo HEO; Hee-jung YOON; Hyung-Mo SUNG; Jonghun LEE; Won-Myong BAHK.
Clinical Psychopharmacology and Neuroscience ; : 143-153, 2022.
Artículo en Inglés | WPRIM | ID: wpr-924826

Documentos relacionados

  1. Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial.
  2. Effects of methylphenidate on mismatch negativity and P3a amplitude of initially psychostimulant-naïve, adult ADHD patients.
  3. Randomised controlled trial of the short-term effects of osmotic-release oral system methylphenidate on symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder: CIAO-II study.
  4. l-Arginine/nitric oxide pathway and oxidative stress in adults with ADHD: Effects of methylphenidate treatment.
  5. The Use of Brexpiprazole Combined With a Stimulant in Adults With Treatment-Resistant Attention-Deficit/Hyperactivity Disorder.
  6. Drug holidays may not affect processing speed while they may reduce beneficial effects on resistance to interference among children with treated with methylphenidate: a single-center, prospective study.
  7. Efficacy and safety of tipepidine as adjunctive therapy in children with attention-deficit/hyperactivity disorder: Randomized, double-blind, placebo-controlled clinical trial.
  8. Clinical characteristics of children and adolescents with ADHD with or without methylphenidate prescription at their first diagnostic assessment.
  9. [The Impact of Psychostimulants on Sleep in Children with Attention Deficit Hyperactivity Disorder: A Systematic Review of Polysomnography Studies].
  10. Osmotic Release Oral System-Methylphenidate Hydrochloride (OROS-MPH) versus atomoxetine on executive function improvement and clinical effectiveness in ADHD: A randomized controlled trial.